Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Luxcore selects INAP to support their ground breaking second generation LambdaRouterTM --- the first full wavelength optical router. INAP chosen for its global presence in strategic markets, carrier...
-
GRAPEVINE, Texas, Nov. 09, 2017 (GLOBE NEWSWIRE) -- While other retailers are revealing their Black Friday deals, GameStop is giving gamers and savvy shoppers a jump-start on holiday deals this...
-
VANCOUVER, British Columbia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Mojio, the leading open platform for connected cars, received a Companies-to-Watch award that recognizes early-stage companies with...
-
BELLEVILLE, Wis., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ:DLTH), a lifestyle brand of men’s and women’s casual wear, workwear...
-
BURLINGTON, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Nuance Communications, Inc. (NASDAQ:NUAN), a leading provider of voice and language solutions, today announced that its Dragon TV voice...
-
Washington, DC, Nov. 09, 2017 (GLOBE NEWSWIRE) -- National nonprofit Jobs for the Future (JFF), and their partners, today will host Celebrate Apprenticeship and Work-Based Learning, an event at the...
-
PHILADELPHIA and OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, released updated data from the...
-
THUNDER BAY, Ontario, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Zenyatta Ventures Ltd. (“Zenyatta” or “Company”) (TSXV:ZEN) is pleased to announce the commencement of a collaborative research project with...
-
SANTA FE, N.M., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today...
-
CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...